Biomarin Pharmaceutical (BMRN) Revenue Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.69 Bn | 9.47 Bn | 571.21 Mn | 8.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.71% |
| Dec 31, 2025 | 17.61% |
| Sep 30, 2025 | 15.38% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 12.79% |
| Dec 31, 2024 | 18.44% |
| Sep 30, 2024 | 22.19% |
| Jun 30, 2024 | 12.38% |
| Mar 31, 2024 | 10.11% |
| Dec 31, 2023 | 12.64% |
| Sep 30, 2023 | 6.83% |
| Jun 30, 2023 | 11.50% |
| Mar 31, 2023 | 5.91% |
| Dec 31, 2022 | 5.76% |
| Sep 30, 2022 | 3.10% |
| Jun 30, 2022 | 11.24% |
| Mar 31, 2022 | 9.03% |
| Dec 31, 2021 | 8.39% |
| Sep 30, 2021 | 1.43% |
| Jun 30, 2021 | 10.40% |